Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel voltage-gated K(V)7 potassium channel modulator has anticonvulsant activity

Nov. 15, 2011

Effect of hepatic impairment on single-dose pharmacokinetics of daclatasvir investigated

Nov. 15, 2011

New PAI-1 inhibitor ameliorates experimental collapsing focal segmental glomerulosclerosis

Nov. 15, 2011

Analgesia seen with NP-2 in phase I study

Nov. 14, 2011

Pharmacokinetics and safety of E-7050 assessed in humans

Nov. 14, 2011

PRT-201 shows promise in patients with kidney disease on hemodialysis

Nov. 14, 2011

Novel clinical data and analyses presented on Regeneron's rilonacept

Nov. 14, 2011

Tocilizumab assessed in large vessel vasculitis

Nov. 14, 2011

LB-80380 compared to entecavir in phase IIb trial

Nov. 14, 2011

Hepatitis C virus resistance characterized in multiple-dose trial of GS-5885

Nov. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...